Key Details
Price
$1.68Annual ROE
45.99%Beta
1.26Events Calendar
Next earnings date:
Mar 4, 2025Recent quarterly earnings:
Nov 7, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 11, 25 JMP Securities
Market OutperformFeb 11, 25 HC Wainwright & Co.
BuyJan 23, 25 JMP Securities
Market OutperformJan 23, 25 HC Wainwright & Co.
BuyJan 22, 25 HC Wainwright & Co.
BuyJan 10, 25 HC Wainwright & Co.
BuyDec 17, 24 Cantor Fitzgerald
OverweightDec 13, 24 Needham
BuyDec 13, 24 HC Wainwright & Co.
BuyDec 12, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Esperion Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Esperion Therapeutics?
- Does Esperion Therapeutics pay dividends?
- What sector is Esperion Therapeutics in?
- What industry is Esperion Therapeutics in?
- What country is Esperion Therapeutics based in?
- When did Esperion Therapeutics go public?
- Is Esperion Therapeutics in the S&P 500?
- Is Esperion Therapeutics in the NASDAQ 100?
- Is Esperion Therapeutics in the Dow Jones?
- When was Esperion Therapeutics's last earnings report?
- When does Esperion Therapeutics report earnings?
- Should I buy Esperion Therapeutics stock now?
What is the ticker symbol for Esperion Therapeutics?
The ticker symbol for Esperion Therapeutics is NASDAQ:ESPR
Does Esperion Therapeutics pay dividends?
No, Esperion Therapeutics does not pay dividends
What sector is Esperion Therapeutics in?
Esperion Therapeutics is in the Healthcare sector
What industry is Esperion Therapeutics in?
Esperion Therapeutics is in the Drug Manufacturers - Specialty & Generic industry
What country is Esperion Therapeutics based in?
Esperion Therapeutics is headquartered in United States
When did Esperion Therapeutics go public?
Esperion Therapeutics's initial public offering (IPO) was on June 26, 2013
Is Esperion Therapeutics in the S&P 500?
No, Esperion Therapeutics is not included in the S&P 500 index
Is Esperion Therapeutics in the NASDAQ 100?
No, Esperion Therapeutics is not included in the NASDAQ 100 index
Is Esperion Therapeutics in the Dow Jones?
No, Esperion Therapeutics is not included in the Dow Jones index
When was Esperion Therapeutics's last earnings report?
Esperion Therapeutics's most recent earnings report was on Nov 7, 2024
When does Esperion Therapeutics report earnings?
The next expected earnings date for Esperion Therapeutics is Mar 4, 2025
Should I buy Esperion Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions